NanoViricides, Inc. (NNVC.OB) Closing In On Magic Bullet
Anil Diwan, Ph.D., president of NanoViricides, Inc., a development stage company creating special purpose nanomaterials for viral therapy, revealed the remarkable potential of this new class of drugs for the treatment of viral disease in a presentation given at the 8th annual NanoBusiness Conference in Chicago recently. NanoViricides has created a class of drug candidates, under the Nanoviricide™ name, that comes as close as anything to the sought after “magic bullet”, able to zero in on specific virus particles and dismantle them. The company is already developing drugs against a number of viral diseases, including H1N1 swine flu, H5N1 bird…